A Whitmer, phD Context: Depression and dementia are common in older adults and often co-occur, but it is unclear whether de pression is an etiologic risk factor for dementia.
A T PRESENT, 5.3 MILLION IN dividuals in the United
States have Alzheimer dis ease (AD), and the associ ated health care costs in 2010 were $172 billion.! Prevalence and costs of AD and other dementias are pro jected to rise dramatically during the next 40 years unless a prevention or a cure can be found 2 Therefore, it is critical to gain a greater understanding of the key risk fac tors and etiologic underpinnings of de mentia from a population-based perspec tive.
Depression commonly occurs in indi viduals with cognitive impairment and de mentia. 3 Although some studies have found that depression coincides with 4 -6 or follows 7 ,8 the onset of dementia in older adults, most studies and several meta analyses have concluded that depression precedes dementia and is associated with approximately a 2-fold increase in the risk of developing cognitive impairment or de mentia. 9 -16 It remains controversial, how ever, whether depression reflects an etio logic risk factor, is part of the dementia prodrome, or shares genetic or other neu ropathologic fea tures with dementia. 10, 17 Vascular disease has been hypoth esized as one of the potential mecha nisms underlying the association be tween depression and dementia.!8 Evidence suggests a reCiprocal relationship be tween vascular disease and depression, in which each condition is associated with an increased risk of developing the o ther. [19] [20] [21] Growing evidence also suggests that vas- cular disease contributes to the clinical manifestation of dementia symptoms. 22 . 24 Several cross-sectional studies have found that depressive symptoms are more com mon in vascular dementia (VaD) than AD, pro vides some support for the vascular disease-depression dementia hypothesis. However, to our knowledge, prior studies have not determined whether depression is more likely to lead to VaD longitudinally, which would pro vide greater support for an etiologic association attrib utable to vascular disease.
Another limitation of most prior studies in this area is they have had relatively short follow-up periods. Given that dementia has a long preclinical period, these stud ies cannot clearly differentiate between etiologic risk fac tors and symptoms of preclinical disease. life course studies with extended follow-up periods are critical for clarifying the timing and nature of the association be tween depression and dementia.
We examined the association between symptoms and dementia during 45 years in a longitudi nal study of more than 13 000 long-term members of the Kaiser Permanente Medical Care Program of Northern California. The primary goals of our study were to (1) clarify the timing of the association by examining the ef fects of depressive in rnidlife and late life and (2) clarify the role vascular disease by examining as sociations with AD and VaD separately.
STUDY POPULATION
The study population consisted of members of the Kaiser Perma nente Medical Care Program of Northern California (herein after referred to as Kaiser) who participated in a voluntary health examination called the Multiphasic Health Checkup (MHC) in San Francisco and Oakland from 1964 through 1973 when they were 40 to 55 years of age. Kaiser is a nonprofit, integnned health maintenance organization that provides comprehensive inpa tient and outpatient care to more than one-fourth of the popu lation in the geographic areas served. were per formed by experienced Kaiser data analysts. maXImIze pa tient confidentiality, non-Kaiser investigators were provided with data summaries only.
MIDLIFE DEPRESSIVE SYMPTOMS
As part of the midlife health survey, Kaiser members were asked: "Do you often feel unhappy or depressed?" Study who answered yes to this question were classified as pressive symptoms in midlife. We also searched tion records and classified individuals who were for depression from 1971 through 1979 as haVing pressive symptoms. Depression was determined using the fol lowing diagnostic codes from the International Classification of Diseases, Ninth Revision (ICD-9): 296.2 (major depressive dis order), 296.3 (recurrent major depressive disorder), 298.0 (de pressive-type psychosis), 300.4 ( dysthymic disorder), and 311. 0 (depressive disorder not elsewhere classified). Of those clas sified as having midlife depressive symptoms, S.7% had been hospitalized for their depression; of these, 57.6% also an swered yes to the survey question on depressive symptoms.
LATE-LIFE DEPRESSIVE SYMPTOMS
Late-life depression was detennined by searching Kaiser's com prehensive electronic medical record database system, which includes diagnoses from all inpatient and outpatient encoun ters at Kaiser medical centers and clinics, for depression noses from]anuary 1, 1994. through December31, 2000, the same ICD-9 codes described. Additional episodes of late life depression were identified by searching hospitalization rec ords from January 1, 1990, through December 31,1999.
DEMENTIA DIAGNOSES
Dementia diagnoses were determined from Kaiser's electronic medical record system from January 1, 2003, through July 31, 2009. We used a 3-year between depression diagnoses and dementia ascertainment to ensure that our dementia cases reflected incident diagnoses.
ICD-9 diagnoses in cluded AD (331.0), VaD presenile/senile dementia (290.0 and 290.10), dementia with depressive features (290.13, 290.21, and 290.43), and dementia with behavioral distur bances (294.10 and 294.11).
All diagnoses were used for analyses of all-cause dementia. Analyses of AD and VaD were restricted to diagnoses made in neu rology clinics to maximize diagnostic specificity. In these analy ses, individuals who developed other of dementia were ex cluded. We have preViously used procedures to identify cases of dementia, AD, and VaD among Kaiser members. 29 • 31 
OTHER MEASURES
The MHC questionnaire included a detailed interview on de mographics, health behaviors, health status, medical con cli tions, and family history. Race/ethnicity was self-reported as Asian, black, white, or other and was included in analyses as a potential confounder. In addition to the MHC questionnaire, several clinical measurements were also collected at the midlife examination, including height, weight, and systolic and dia stolic blood pressure. Height and weight were combined to cal culate body mass index. Participants were considered to have midlife hypertension if they had 1 of the following: a self report of physician-diagnosed hypertenSion, use of antihyper tensive medication, systolic blood pressure of at least 140 mm Hg, or diastolic blood pressure of at least 90 mm Hg. Midlife diabetes status was defined by a self-repon of physician diagnosed diabetes mellitus, use of insulin or oral hypoglyce mic agents, a fasting (last food eaten in 2.:8 hours) glucose level of at least 140 mgldL or a nonfasting (last food eaten in hours) glucose level of at least 200 mgldL (to convert glucose levels to millimoles per liter, multiply by 0.0555). Diagnoses of stroke, hypertension, and cardiovascular dis ease also were recorded from outpatient records and hospital discharge diagnoses from 1978 through the end of the study using the following ICD-9 codes: ischemic stroke (433-438), hemorrhagic stroke (430-432), and cardiovascular disease (410, 411,413,414,428,440,443, and V717).
ANALYSES
Subjects were classified into one of the follOwing 4 depression groups according to depressive symptoms: none, midlife onlv, late life only, or midlife and late life. Those with no depressi~e symptoms were used as the comparison group in all analyses. The unadjusted percentage of individuals who developed de mentia, AD, and VaD was compared across the depression groups using X" tests. Survival analysis and Cox proportional hazards models using age as the timescale were used to compare the Figure 2 .
------.....,.'mMIi §· _------In this study of more than 13 000 long-term Kaiser mem bers, depressive symptoms in midlife or in late life were associated with an increased risk of developing demen tia. In addition, the risk of AD was approximately doubled in individuals with depressive symptoms in late life (alone or in combination with midlife symptoms), whereas the risk of VaD was more than tripled in those with midlife and late-life depressive symptoms. These findings have important public health implications because they raise hope that adequate treatment of depres..sion in midlife may reduce dementia risk in late life. 
9 -I6 They also are consistent with a small number of prior studies suggesting that de pression earlier in life also is associated with an in creased risk of dementia. An early case-control study found that depression was associated with increased dementia risk even if the first episode occurred 25 years before on set,33 and a more recent study found an association be tween the number of depressive episodes and risk of de mentia during 25 years. IS However, these studies did not differentiate between single vs recurrent depressive epi sodes and, therefore, did not explicitly examine demen tia risk in the subset of subjects who only had depres sive symptoms in midlife.
There has been an ongoing debate in the field as to whether the association between depression and demen tia reflects an etiologic relationship or whether depres sion is a prodromal symptom of dementia lO .l 7 Our re sults suggest that the answer may differ depending on the dementia subtype. Depression that presents for the first time in late life may reflect the earliest symptoms of dementia, particularly AD, in some individuals. Future studies should examine whether it may be helpful clini cally to monitor these individuals for symptoms of cog nitive deterioration suggestive of dementia. It is pos sible that earlier recognition of dementia could facilitate better management of health care through earlier treat ment with memory-enhancing agents, when they are most likely to be effective, as well as greater involvement of caregivers, simplification of medication regimens, and ear lier discussions regarding goals of care.
On the other hand, recurrence of depression in late life may reflect a long-term process of subclinical cerebrovas cular changes that may predispose toward development of VaD. This hypothesis is consistent "vith the vascular disease depression-dementia hypothesis 18 and is supported by prior studies in which white matter hyperintensities on cere bral magnetic resonance images--which are considered to be markers of underlying cerebrovascular disease-are as sociated with greater risk of depression and dementia in late life.
3437 Although our study provides support for the vascular disease-depression-dementia hypothesis, it re mains possible that other hypothesized mechanisms also playa role in the association between depreSSion and de mentia. In particular, the hypothalamic-pituitary-adrenal axis has been proposed as an alternative mechanism in which chronic or recurrent depression leads to hypercor tisolemia that in turn results in hippocampal damage and increased vulnerability to dementia yo Strengths of this study include the large sample size, which enabled us to study VaD as well as AD; the inte grated health care delivery setting, which minimizes the impact of access to health care and enabled us to adjust for other medical comorbidities during the lifespan; and the availability of data from midlife and late life, which enabled us to examine depression during the life course. Limitations of the study include the midlife depressive symptom measure, which was based primarily on a single self-reported question and likely resulted in lack of speci ficity. In addition, use of electronic medical record data
for diagnoses oflate-life depression and dementia likely resulted in 1m·; sensitivity and underrecognition of these conditions. \Ye also were not able to confirm diagnoses of AD and VaD using operational criteria or through post mortem or neuroimaging studies. Given that vascular dis ease is an independent risk factor for AD, that pure VaD is relatively rare, and that most individuals with demen tia at the population leyel have mixed ADNaD pathol ogy, some VaD diagnoses in this study may have re flected a more mixed etiology_ To the extent that these misclassifications were nondifferential (ie, misclassifi cation of depressive symptom status was similar in those with and without dementia diagnoses, and misclassifi cation of dementia status was similar in those with and without depressive symptoms). our findings would be biased toward the null; thus, the true magnitude of these associations may be stronger than observed in this study. \Ve also were unable to analyze data related to use of an tidepressants or other psychotropic medications, which should be examined in future studies. In addition, our measures of vascular risk factors were relatiyelv limited, so we were unable to directly examine the role of vas cular disease as the etiologic mediator of the association between depression and VaD. Finally, because ,,-e ex cluded dementia cases diagnosed before January 1, 2003, our findings are restricted to late-life dementia.
Our findings suggest that chronic depression during the life course may be etiologically associated with an in creased risk of dementia, particularly VaD, whereas de pression that occurs for the first time in late life is likely to reflect a prodromal stage of dementia, in particular AD. Future studies are needed to determine whether ad equate treatment of depre.<;sion in midlife or in late life may help to maintain cognitive function and delay de mentia onset. Given the anticipated increase in demen tia prevalence during the next 40 years, even a small re duction in dementia risk would have a tremendous public health impact. 3s WWW.ARCHGENPSYCHIATRYCOMmanagement, analysis, or interpretation of the data; or in the preparation, review, or approval of the manu- 
